🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Cognitive impairment is a key disabling feature of SZ. The impairment affec...
Status
Completed
Location
Multiple Locations
Start Date
2010-08
Trial ID
NCT01879709
Treatments Being Tested
A protocol named as "HLH-DR" for patients with refractory and secondary hem...
Status
Unknown
Location
Yan Yue
Start Date
2017-03-01
Trial ID
NCT03795909
Treatments Being Tested
This is a randomized, double-blind, placebo-controlled, parallel group, mul...
Status
Completed
Location
University of California, San Diego
Start Date
2021-05-21
Trial ID
NCT04535609
Treatments Being Tested
The purpose of this study is to determine if giving a larger amount of DHA ...
Status
Completed
Location
University of Kansas Medical Center
Start Date
2016-06-08
Trial ID
NCT02626299
Treatments Being Tested
To compare the efficacy and safety of Agnucaston tablets with placebo for t...
Status
Completed
Location
Peking Union Medical College Hospital
Start Date
2005-02
Trial ID
NCT00672607
Treatments Being Tested
This Phase III clinical trial is designed to assess the efficacy and safety...
Status
Recruiting
Location
Shanghai Changhai Hospital
Start Date
2025-07-30
Trial ID
NCT07010107
Treatments Being Tested
This is a multi-center, randomized, double blind, placebo-controlled phase ...
Status
Completed
Location
Beijing Chao-Yang Hospital, Capital Medical University
Start Date
2021-02-24
Trial ID
NCT04805411
The objective of this study was to evaluate efficacy and safety of regorafe...
Status
Completed
Location
Multiple Locations
Start Date
2013-05-14
Trial ID
NCT01774344
Treatments Being Tested
Prospective, double-blind, randomized assessment of the efficacy, safety an...
Status
Completed
Location
Research Site 1
Start Date
2017-03-29
Trial ID
NCT03027609
This is a Phase 3, randomized, double-blind clinical trial aimed at evaluat...
Status
Recruiting
Location
Harbin Medical University Cancer Hospital
Start Date
2025-06-11
Trial ID
NCT06953999